Study Site 159 — Hackensack, New Jersey

Study Site 159 is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 159 has participated in 1 clinical trials.

Therapeutic areas: Prurigo Nodularis.

Sponsors: Trevi Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 159?

Study Site 159 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 159 conducted?

Study Site 159 has 1 clinical trials on record. Their work covers Prurigo Nodularis.

Is Study Site 159 accredited by Crixeo Health?

Study Site 159 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 159?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.